When was eNLife Research founded?

eNLife Research was founded in 2025 and raised its 1st funding round 1 year after it was founded.

Where is eNLife Research located?

eNLife Research is headquartered in India. It is registered at C/O 1A RAHEJA PLAZA L B S MARG, GHATKOPAR WEST, Mumbai City, MUMBAI, Maharashtra, India, 400086.

Which legal entities is eNLife Research associated with?

eNLife Research is associated with ENLIFE SCIENCES PRIVATE LIMITED.

How many employees does eNLife Research have?

As of Sep 30, 2026, the latest employee count at eNLife Research is 6.

Is eNLife Research a funded company?

eNLife Research is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jul 08, 2026.

How much is eNLife Research worth?

The latest valuation of eNLife Research is ₹***** as of Jul 08, 2026.

When was the latest funding round of eNLife Research?

eNLife Research's latest funding was a $***** Seed round on Jul 08, 2026, with participation from 1 investor.

Where does eNLife Research rank among its competitors?

eNLife Research ranks 21st amongst 47 active competitors, of which 18 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was ALZpath, which secured $8.41M in Jul, 2026.

Who are the top competitors of eNLife Research?

eNLife Research's top competitors include NeuroDex, C₂N Diagnostics and ALZpath. Among them, ALZpath secured the most recent funding round in July, 2026.

eNLife Research - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of innovative biomarker-based diagnostic solutions for the early detection of neurodegenerative diseases. The organization focuses on creating a comprehensive pipeline that encompasses detection, precision therapeutic interventions, and personalized strategies for conditions such as Alzheimer's disease. By utilizing advanced research and diagnostic technologies, the firm aims to identify neurological conditions before symptoms appear, facilitating timely intervention and improved patient outcomes. The approach integrates biomarker discovery, precision medicine, and end-to-end diagnostic tools to support healthcare providers in managing complex neurological health challenges.

Website: enlife.in
Email ID: *****@enlife.in
Registered Address: C/O 1A RAHEJA PLAZA L B S MARG, GHATKOPAR WEST, Mumbai City, MUMBAI, Maharashtra, India, 400086

Key Metrics

Founded Year

2025

Location

India

Stage

Seed

Total Funding

$630K in 1 round

Latest Funding Round

Seed, Jul 08, 2026, $*****

Post Money Valuation

₹***** as on Jul 08, 2026

Investors

Piper Serica & 1 more

Ranked

21^st among 47 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

NeuroDex & 60 more

View eNLife Research's full profile

eNLife Research is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
ENLIFE SCIENCES PRIVATE LIMITED CIN: U24117MH2007PTC168128 , India, Strike off	Feb 24, 2007	-	-

eNLife Research has raised a total funding of $630K over 1 round. Its latest funding round was a Seed round on Jul 08, 2026 for $*****. 1 investor participated in its latest round. eNLife Research has 2 institutional investors.

Here is the list of recent funding rounds of eNLife Research:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 08, 2026	5088412	Seed	1714571	4914922	4527479	3052124

Access funding benchmarks and valuations. Sign up today!

View details of eNLife Research's funding rounds and investors

eNLife Research's Board of Directors

eNLife Research's board has 2 active members. Mona Akshay Mehta and Akshay Girjashankar Mehta are independent board members.

Here is the list of eNLife Research's board of directors:

Name	Type	Representing	Status	Duration
Mona Akshay Mehta	Independent board member	-	Current	19y 8m
wvstjln	Independent board member	-	Current	1y 1m

eNLife Research's employee count trend

eNLife Research has 6 employees as of Sep 26. Here is eNLife Research's employee count trend over the years:

Employee count trend for eNLife Research

Uncover eNLife Research's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of eNLife Research include NeuroDex, C₂N Diagnostics and ALZpath. Here is the list of Top 10 competitors of eNLife Research, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroDex 2018, Natick (United States), Seed	Manufacturer of diagnostic tools for Alzheimer's disease	$1.36M	ICV, Military Health & 1 others	58/100
2nd	C₂N Diagnostics 2007, St. Louis (United States), Series B	Developer of diagnostics and therapies for Alzheimer's disease	$35M	Eisai, Samsung Venture Investment & 6 others	58/100
3rd	ALZpath 2020, Carlsbad (United States), Series A	Developer of diagnostic solutions for Alzheimer's Disease	$8.41M	Stead Impact Ventures, Alzheimer's Drug Discovery	55/100
4th	Amydis Diagnostics 2013, San Diego (United States), Series A	Developer of diagnostics test for detection of Alzheimer's disease	$8.69M	NIA, Springboard Enterprises & 4 others	53/100
5th	Todos Medical 2009, Rehovot (Israel), Public	Developer of in vitro diagnostics for the detection of cancer and neurodegenerative disorders	-	Lincoln Park Capital, Yozma & 2 others	47/100
6th	DiamiR 2009, Monmouth Junction (United States), Funding Raised	Developer of minimally invasive diagnostic tests	-	NIA, HHS	45/100
7th	ADmit Therapeutics 2017, Barcelona (Spain), Series A	Provider of diagnostic services for early detection of Alzheimer's disease	$12.9M	Ship2B, Clave & 13 others	42/100
8th	Lucent Diagnostics 2023, Billerica (United States), Unfunded	Developer of a biomarker blood test for the diagnosis of Alzheimer's disease	-	-	40/100
9th	bioLOCKEY Healthworks 2023, Bengaluru (India), Seed	Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform	$478K	Pfizer, Pfizerindovation & 7 others	37/100
10th	Veravas 2017, Oakdale (United States), Series A	Provider of platform to manage sample preparation and diagnostic solutions	$25M	SeedFunders	37/100
21st	eNLife Research 2025, India, Seed	Developer of innovative biomarker-based diagnostic solutions for the early detection of neurodegenerative diseases	$630K	Piper Serica, Foundation for Science Innovation and Development ... Read more	36/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on eNLife Research's competitors? Click here to see the top ones

Founders (largest shareholder) own 60.75%, Funds own 31.75% and ESOP Pool own 7.50%. The net worth of eNLife Research's founders is INR 14.6Cr as of Jul 08, 2026. The cap table displayed below is for ENLIFE SCIENCES PRIVATE LIMITED which is the legal entity associated with eNLife Research.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	60.75%	14.6Cr	1140509	3520992	2385774	9309434
Fund	31.75%	7.62Cr	7006504	3423155	5582938	2600050
Piper Serica	1263246	4523841	7415398	9141633	8426845	7998842
ESOP Pool	7.50%	1.8Cr	5000619	1049094	6159968	6956984
Total	100.00%	24Cr	7570963	1948565	7990715	5539909